Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,16 USD | +2,37% | +4,35% | +22,73% |
07/05 | Insider bij Corvus Pharmaceuticals kocht aandelen ter waarde van $1.000.000, volgens een recent SEC-document | MT |
07/05 | CORVUS PHARMACEUTICALS, INC. : Oppenheimer handhaaft koopadvies | ZM |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 135 mln. 125 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -30 mln. -27,66 mln. | Nettowinst (verlies) 2025 * | -45 mln. -41,49 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-4,5
x | K/w-verhouding 2025 * |
-3,96
x | Werknemers | 28 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,74% |
Recentste transcriptie over Corvus Pharmaceuticals, Inc.
1 dag | +2,37% | ||
1 week | +4,35% | ||
Lopende maand | +39,35% | ||
1 maand | +39,35% | ||
3 maanden | -0,92% | ||
6 maanden | +41,18% | ||
Lopend jaar | +22,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27-01-14 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 27-01-14 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27-01-14 |
Ian Clark
BRD | Director/Board Member | 62 | 03-01-17 |
Terry Gould
BRD | Director/Board Member | 67 | 01-11-14 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
31-05-24 | 2,16 | +2,37% | 52 286 |
30-05-24 | 2,11 | +0,48% | 132 142 |
29-05-24 | 2,1 | +3,96% | 123 166 |
28-05-24 | 2,02 | -1,94% | 458 882 |
24-05-24 | 2,06 | -0,48% | 169 009 |
uitgestelde koers Nasdaq, 31 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,73% | 132 mln. | |
+43,36% | 58,06 mld. | |
-5,31% | 40,53 mld. | |
+37,52% | 38,99 mld. | |
+14,75% | 26,7 mld. | |
-12,56% | 26,56 mld. | |
-22,45% | 18,98 mld. | |
+0,04% | 12,17 mld. | |
+25,12% | 12 mld. | |
+26,04% | 11,92 mld. |